STAT3 drives the expression of ACSL4 in acute kidney injury.

Integrative aspects of cell biology omics pathophysiology

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
21 Jun 2024
Historique:
received: 20 11 2023
revised: 27 02 2024
accepted: 10 04 2024
medline: 27 5 2024
pubmed: 27 5 2024
entrez: 27 5 2024
Statut: epublish

Résumé

Long-chain acyl-CoA synthetase family 4 (ACSL4) metabolizes long-chain polyunsaturated fatty acids (PUFAs), enriching cell membranes with phospholipids susceptible to peroxidation and drive ferroptosis. The role of ACSL4 and ferroptosis upon endoplasmic-reticulum (ER)-stress-induced acute kidney injury (AKI) is unknown. We used lipidomic, molecular, and cellular biology approaches along with a mouse model of AKI induced by ER stress to investigate the role of ACSL4 regulation in membrane lipidome remodeling in the injured tubular epithelium. Tubular epithelial cells (TECs) activate ACSL4 in response to STAT3 signaling. In this context, TEC membrane lipidome is remodeled toward PUFA-enriched triglycerides instead of PUFA-bearing phospholipids. TECs expressing ACSL4 in this setting are not vulnerable to ferroptosis. Thus, ACSL4 activity in TECs is driven by STAT3 signaling, but ACSL4 alone is not enough to sensitize ferroptosis, highlighting the significance of the biological context associated with the study model.

Identifiants

pubmed: 38799564
doi: 10.1016/j.isci.2024.109737
pii: S2589-0042(24)00959-3
pmc: PMC11126884
doi:

Types de publication

Journal Article

Langues

eng

Pagination

109737

Informations de copyright

© 2024 The Author(s).

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Auteurs

Virginie Poindessous (V)

Centre de Recherche des Cordeliers, INSERM U1138, Université Paris Cité, Paris, France.

Helene Lazareth (H)

Centre de Recherche des Cordeliers, INSERM U1138, Université Paris Cité, Paris, France.
Université Paris-Cité, Paris, France.
Laboratory of Renal Physiology and Tubulopathies, Centre de Recherche des Cordeliers, INSERM U1138, Sorbonne Université, Université Paris Cité, Paris, France.

Gilles Crambert (G)

EMR 8228 Metabolism and Renal Physiology Unit, CNRS, Paris, France.
CurieCoreTech Metabolomics and Lipidomics Technology Platform, Institut Curie, Paris, France.

Lydie Cheval (L)

EMR 8228 Metabolism and Renal Physiology Unit, CNRS, Paris, France.
CurieCoreTech Metabolomics and Lipidomics Technology Platform, Institut Curie, Paris, France.

Julio L Sampaio (JL)

CurieCoreTech Metabolomics and Lipidomics Technology Platform, Institut Curie, Paris, France.

Nicolas Pallet (N)

Laboratory of Renal Physiology and Tubulopathies, Centre de Recherche des Cordeliers, INSERM U1138, Sorbonne Université, Université Paris Cité, Paris, France.
Department of Clinical Chemistry, Assistance Publique Hôpitaux de Paris, Georges Pompidou European Hospital, Paris, France.

Classifications MeSH